Skip to Main Content

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies (CRETE)

Conditions

Diseases of the Cardiovascular System

Phase II-III

What is the purpose of this trial?

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.

  • Trial with
    National Institutes of Health (NIH)
  • Start Date
    05/11/2022
  • End Date
    04/30/2026

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    05/18/2022
  • Study HIC
    #2000030683